miR-125b: A Potential Early-Stage Biomarker for Alzheimer's Disease Diagnosis and Intervention
MicroRNA-125b (miR-125b) exhibits promise as a valuable biomarker for the early detection of Alzheimer's disease (AD). Early diagnosis is crucial for effective disease management. Utilizing miR-125b as a diagnostic tool could enable clinicians to make prompt treatment decisions, potentially slowing the severe neurological deterioration associated with AD progression.
原文地址: https://www.cveoy.top/t/topic/fvXY 著作权归作者所有。请勿转载和采集!